Onishi T, Fukuda Y, Miyazaki S, et al. Practical guidance for echocardiography for cancer therapeutics-related cardiac dysfunction. J Echocardiogr. 2021;19:1–20.

Article  PubMed  Google Scholar 

Lyon AR, Lopez-Fernandez T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229–361.

Article  PubMed  Google Scholar 

Japanese Society of Medical Oncology. Japanese Society of Cardio-Oncology. Onco-cardiology guidelines. Tokyo: Nankodo; 2023. ((in Japanese)).

Google Scholar 

National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 6.0. 2025.

Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344:783–92.

Article  CAS  PubMed  Google Scholar 

Jeyaprakash P, Sangha S, Ellenberger K, et al. Cardiotoxic effect of modern anthracycline dosing on left ventricular ejection fraction: A systematic review and meta-analysis of placebo arms from randomized controlled trials. J Am Heart Assoc. 2021;10:e018802.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131:1981–8.

Article  CAS  PubMed  Google Scholar 

Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213–20.

Article  CAS  PubMed  Google Scholar 

Kitai T, Kohsaka S, Kato T, et al. JCS/JHFS 2025 guideline on diagnosis and treatment of heart failure. Circ J. 2025;89:1278–444.

Article  PubMed  Google Scholar 

American College of Cardiology Foundation Appropriate Use Criteria Task F, American Society of E, American Heart A et al: ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr 2011;24:229–67.

Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr. 2003;16:1091–110.

PubMed  Google Scholar 

Daher IN, Kim C, Saleh RR, et al. Prevalence of abnormal echocardiographic findings in cancer patients: a retrospective evaluation of echocardiography for identifying cardiac abnormalities in cancer patients. Echocardiography. 2011;28:1061–7.

Article  PubMed  Google Scholar 

Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15:1063–93.

Article  PubMed  PubMed Central  Google Scholar 

Wood PW, Choy JB, Nanda NC, et al. Left ventricular ejection fraction and volumes: it depends on the imaging method. Echocardiography. 2014;31:87–100.

Article  PubMed  Google Scholar 

Medvedofsky D, Mor-Avi V, Byku I, et al. Three-dimensional echocardiographic automated quantification of left heart chamber volumes using an adaptive analytics algorithm: feasibility and impact of image quality in nonselected patients. J Am Soc Echocardiogr. 2017;30:879–85.

Article  PubMed  PubMed Central  Google Scholar 

Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70.

Article  PubMed  Google Scholar 

Isner JM, Ferrans VJ, Cohen SR, et al. Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy. Am J Cardiol. 1983;51:1167–74.

Article  CAS  PubMed  Google Scholar 

Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.

Article  PubMed  Google Scholar 

Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2768–801.

Article  PubMed  Google Scholar 

Group ESCSD. [2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)]. G Ital Cardiol (Rome). 2023;24:e1–130.

Google Scholar 

Japanese Society of Cardio-Oncology Editorial Committee. Handbook of cardio-oncology practice. Tokyo: Medical View; 2020. (in Japanese)

Thavendiranathan P, Grant AD, Negishi T, et al. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61:77–84.

Article  PubMed  Google Scholar 

Thomas JD, Edvardsen T, Abraham T et al: Clinical applications of strain echocardiography: A clinical consensus statement from the American Society of Echocardiography Developed in Collaboration with the European Association of Cardiovascular Imaging of the European Society of Cardiology. J Am Soc Echocardiogr 2025;

Takigiku K, Takeuchi M, Izumi C, et al. Normal range of left ventricular 2-dimensional strain: Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE) study. Circ J. 2012;76:2623–32.

Article  PubMed  Google Scholar 

Mousavi N, Tan TC, Ali M, et al. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines. Eur Heart J Cardiovasc Imaging. 2015;16:977–84.

PubMed  Google Scholar 

Rhea IB, Uppuluri S, Sawada S, et al. Incremental prognostic value of echocardiographic strain and its association with mortality in cancer patients. J Am Soc Echocardiogr. 2015;28:667–73.

Article  PubMed  Google Scholar 

Ali MT, Yucel E, Bouras S, et al. Myocardial strain is associated with adverse clinical cardiac events in patients treated with anthracyclines. J Am Soc Echocardiogr. 2016;29:522-7 e3.

Article  PubMed  Google Scholar 

Hatazawa K, Tanaka H, Nonaka A, et al. Baseline global longitudinal strain as a predictor of left ventricular dysfunction and hospitalization for heart failure of patients with malignant lymphoma after anthracycline therapy. Circ J. 2018;82:2566–74.

Article  CAS  PubMed  Google Scholar 

Araujo-Gutierrez R, Chitturi KR, Xu J, et al. Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity. Cardiooncology. 2021;7:4.

PubMed  PubMed Central  Google Scholar 

Thavendiranathan P, Negishi T, Somerset E, et al. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. J Am Coll Cardiol. 2021;77:392–401.

Article  CAS  PubMed  Google Scholar 

Liu Z, Liu M, Zhong X, et al. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer. Cancer Med. 2023;12:13374–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong FF, Grunblatt E, Voss WB, et al. A strain-guided trial of cardioprotection in early-stage breast cancer patients on anti-HER2 therapy (PROTECT HER2). Cardiooncology. 2024;10:85.

PubMed  PubMed Central  Google Scholar 

Rihackova E, Rihacek M, Boucek L, et al. Utility of global longitudinal strain in early identification of chronic cardiotoxicity in asymptomatic long-term malignant lymphoma survivors with normal left ventricle ejection fraction. Sci Rep. 2025;15:9372.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagueh SF, Sanborn DY, Oh JK, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: an update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38:537–69.

Article  PubMed  Google Scholar 

Choi BW, Berger HJ, Schwartz PE, et al. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance. Am Heart J. 1983;106:638–43.

Article  CAS  PubMed  Google Scholar 

Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation. 2009;119:e561–87.

PubMed